| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.39B | $4.97B | $4.43B |
| YoY Revenue Growth % | +8.4% | +12.1% | — |
| Gross Profit | $144.0M | -$1.20B | — |
| Gross Margin % | 2.7% | -24.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$3.58B | -$4.69B | -$5.74B |
| Operating Margin % | -66.5% | -94.3% | -129.4% |
| Net Income (GAAP) | -$3.65B | -$4.75B | -$5.43B |
| EBITDA (Normalized) | -$2.22B | -$3.78B | -$5.58B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$779.0M | -$1.72B | -$4.87B |
| Capital Expenditures (CapEx) | $1.71B | $1.14B | $199.5M |
| Free Cash Flow (FCF) | -$2.49B | -$2.86B | -$5.07B |
| FCF Margin % | -46.2% | -57.5% | -114.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | -45.0% |
| Cash & Short-Term Equivalents | $3.58B | $5.29B | — |
| Total Debt (Short + Long Term) | $4.44B | $4.44B | $2.13B |
| Total Stockholders' Equity | $4.59B | $6.56B | $4.38B |